EMERGENCY LIVER TRANSPLANTATION IN A PATIENT WITH HEPATITIS B VIRUS-RELATED CIRRHOSIS COMPLICATED BY HEPATORENAL SYNDROME: A CLINICAL CASE REPORT
Main Article Content
Abstract
Objectives: To present a clinical case of hepatitis B virus-related (HBV) cirrhosis that developed hepatorenal syndrome - acute kidney injury (HRS-AKI), managed with hemodialysis, plasma exchange, and subsequent liver transplantation; and to discuss diagnostic challenges, therapeutic strategies, and renal function recovery after transplantation. Methods: A case report was conducted on a patient with HRS-AKI who underwent emergency liver transplantation. Results: A 41-year-old male with cirrhosis due to chronic HBV infection, with poor treatment adherence, was admitted in a state of altered consciousness, ascites, and oliguria. Laboratory findings revealed severe progressive hepatic dysfunction and renal impairment. The patient was diagnosed with HRS-AKI after exclusion of other causes of acute kidney injury. Vasoconstrictor therapy and albumin infusion were unsuccessful, necessitating continuous renal replacement therapy and plasma exchange. Emergency liver transplantation was performed 10 days after admission. Five days post-transplant, liver function recovered significantly, and renal function gradually improved, eliminating the need for further dialysis. Conclusion: This case demonstrates that emergency liver transplantation is a life-saving option for patients with HRS-AKI unresponsive to medical therapy. It further highlights the importance of early diagnosis and timely referral to a transplant center.
Keywords
Hepatorenal syndrome, HRS-AKI, Dialysis, Liver transplantation
Article Details
References
2. Nadim MK, Kellum JA, Forni L, et al. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol. 2024; 81:163-183.
3. Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015; 62:968-974.
4. Olson JC, Subramanian RM. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis. PLOS ONE. 2024; 19:e0296690.
5. Piano S, Gambino C, Vettore E, al el. Response to terlipressin and albumin is associated with improved liver transplant outcomes in patients with hepatorenal syndrome. Hepatology. 2021; 73:1909-1919.
6. Rosner MH, Ostermann M, Murugan R, et al. Indications and management of mechanical fluid removal in critical illness. Br J Anaesth. 2014; 113(5):764-771.
7. Saro Khemichian, Mitra K. Nadim, Terrau aNA. Update on hepatorenal syndrome: From pathophysiology to treatment. Annu Rev Med. 2025; 76:373-387.
8. Nadim MK, Sung RS, Davis CL, et al. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012; 12:2901-2908.